Thursday, January 6, 2022

< + > An Interview With The Team Leader For The Scientific Discovery Of Pfizer’s COVID-19 Drug, Paxlovid

In non-hospitalized high-risk adults with COVID-19, Paxlovid was found to reduce the risk of hospitalization or death by 89% compared to placebo.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > Healthcare IT Failures – Healthcare IT Today Podcast Episode 195

For the 195th episode of the Healthcare IT Today Podcast , we are taking a look at healthcare IT failures! We kick this episode off by debat...